Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma

Treatment of Kidney Transplant Recipients With ACEi/ARB and Risk of Respiratory Tract Cancer: A Collaborative Transplant Study Report

(2011) G. Opelz et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update

(2011) Morgan Rouprêt et al.   EUROPEAN UROLOGY

Angiotensin Receptor Blockade and Risk of Cancer in Type 2 Diabetes Mellitus: A Nationwide Case-Control Study

(2011) Chia-Hsuin Chang et al.   JOURNAL OF CLINICAL ONCOLOGY

Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine

(2010) Y Nakai et al.   BRITISH JOURNAL OF CANCER

Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma

(2010) Surena F. Matin et al.   CANCER

Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy

(2010) Brian R. Lane et al.   CANCER

Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma

(2010) Manabu Tatokoro et al.   CANCER SCIENCE

The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center

(2010) Ricardo L. Favaretto et al.   EUROPEAN UROLOGY

Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy

(2010) Matthew G. Kaag et al.   EUROPEAN UROLOGY

Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials

(2010) Ilke Sipahi et al.   LANCET ONCOLOGY

Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer

(2010) N. Tanaka et al.   MOLECULAR CANCER THERAPEUTICS

Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

(2009) Vitaly Margulis et al.   CANCER

A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone

(2009) Xin Li et al.   CANCER RESEARCH

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

(2009) Stefan Wilop et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma

(2009) Hitoshi Yoshiji et al.   JOURNAL OF HEPATOLOGY

Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration

(2009) Nicholas J. Hellenthal et al.   JOURNAL OF UROLOGY

Does the Renin-Angiotensin System Participate in Regulation of Human Vasculogenesis and Angiogenesis?

(2008) A. Y. Khakoo et al.   CANCER RESEARCH

The renin-angiotensin system and malignancy

(2008) E. I. Ager et al.   CARCINOGENESIS

Association of ACE Inhibitors and Angiotensin Receptor Blockers with Keratinocyte Cancer Prevention in the Randomized VATTC Trial

(2008) J. B. Christian et al.   JNCI-Journal of the National Cancer Institute